Found: 22
Select item for more details and to access through your institution.
Interim analyses of the multinational real‐world prospective cohort HEM‐POWR study evaluating the effectiveness and safety of damoctocog alfa pegol in patients with hemophilia A.
- Published in:
- European Journal of Haematology, 2024, v. 112, n. 2, p. 286, doi. 10.1111/ejh.14114
- By:
- Publication type:
- Article
The impact of obesity on chronic pain in patients with haemophilia: A multicentre retrospective analysis.
- Published in:
- Haemophilia, 2024, v. 30, n. 2, p. 567, doi. 10.1111/hae.14962
- By:
- Publication type:
- Article
Prophylaxis use of clotting factor replacement products in people with non‐severe haemophilia: A review of the literature.
- Published in:
- Haemophilia, 2023, v. 29, n. 1, p. 33, doi. 10.1111/hae.14676
- By:
- Publication type:
- Article
PERSEPT 3: A phase 3 clinical trial to evaluate the haemostatic efficacy of eptacog beta (recombinant human FVIIa) in perioperative care in subjects with haemophilia A or B with inhibitors.
- Published in:
- Haemophilia, 2021, v. 27, n. 6, p. 911, doi. 10.1111/hae.14418
- By:
- Publication type:
- Article
Safety and efficacy of BAY 94–9027, an extended‐half‐life factor VIII, during minor surgical procedures in patients with severe haemophilia A.
- Published in:
- Haemophilia, 2021, v. 27, n. 4, p. e559, doi. 10.1111/hae.14319
- By:
- Publication type:
- Article
Confirmed long‐term safety and efficacy of prophylactic treatment with BAY 94–9027 in severe haemophilia A: final results of the PROTECT VIII extension study.
- Published in:
- Haemophilia, 2021, v. 27, n. 3, p. e347, doi. 10.1111/hae.14297
- By:
- Publication type:
- Article
Target joint resolution in patients with haemophilia A receiving long‐term prophylaxis with BAY 94‐9027.
- Published in:
- Haemophilia, 2020, v. 26, n. 4, p. e201, doi. 10.1111/hae.13982
- By:
- Publication type:
- Article
Opioid exposure in haemophilia patients is common and underreported.
- Published in:
- Haemophilia, 2020, v. 26, n. 2, p. 251, doi. 10.1111/hae.13950
- By:
- Publication type:
- Article
BAY 94‐9027 prophylaxis is efficacious and well tolerated for up to >5 years with extended dosing intervals: PROTECT VIII extension interim results.
- Published in:
- Haemophilia, 2019, v. 25, n. 6, p. 1011, doi. 10.1111/hae.13853
- By:
- Publication type:
- Article
Is prophylaxis required for delivery in women with factor VII deficiency?
- Published in:
- Haemophilia, 2013, v. 19, n. 6, p. 827, doi. 10.1111/hae.12167
- By:
- Publication type:
- Article
Integrated Hemophilia Patient Care via a National Network of Care Centers in the United States: A Model for Rare Coagulation Disorders.
- Published in:
- Journal of Blood Medicine, 2021, v. 12, p. 897, doi. 10.2147/JBM.S325031
- By:
- Publication type:
- Article
1081. Targeted Nanocapsules for Liver Cell-Type Delivery of Plasmids In Vivo.
- Published in:
- Molecular Therapy, 2006, v. 13, p. S415, doi. 10.1016/j.ymthe.2006.08.1182
- By:
- Publication type:
- Article
A laparoscopic approach to address massive splenomegaly, symptomatic cholelithiasis, and a planned postoperative pregnancy: A case report.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Response of complex immune-mediated thrombocytopenia to romiplostim in the setting of allogeneic stem cell transplantation for chronic myelogenous leukemia.
- Published in:
- European Journal of Haematology, 2012, v. 89, n. 4, p. 361, doi. 10.1111/j.1600-0609.2012.01832.x
- By:
- Publication type:
- Article
Use of recombinant human antithrombin concentrate in pregnancy.
- Published in:
- 2013
- By:
- Publication type:
- Case Study
Nanocapsule-delivered Sleeping Beauty mediates therapeutic Factor VIII expression in liver sinusoidal endothelial cells of hemophilia A mice.
- Published in:
- 2009
- By:
- Publication type:
- journal article
Barriers to effective diagnosis and management of a bleeding patient with undiagnosed bleeding disorder across multiple specialties: results of a quantitative case-based survey.
- Published in:
- Journal of Multidisciplinary Healthcare, 2012, v. 5, p. 277, doi. 10.2147/JMDH.S35272
- By:
- Publication type:
- Article
Efficacy and safety of damoctocog alfa pegol prophylaxis in patients ⩾40 years with severe haemophilia A and comorbidities: post hoc analysis from the PROTECT VIII study.
- Published in:
- Therapeutic Advances in Hematology, 2023, v. 14, p. 1, doi. 10.1177/20406207231166779
- By:
- Publication type:
- Article
Management Insights for Optimizing Outcomes in the Treatment of Hemophilia.
- Published in:
- Journal of Managed Care Medicine, 2018, v. 21, n. 4, p. 55
- By:
- Publication type:
- Article
Improving Patient Outcomes in the Management of Hemophilia.
- Published in:
- Journal of Managed Care Medicine, 2017, v. 20, n. 1, p. 42
- By:
- Publication type:
- Article
Improving the Management of Severe Hemophilia.
- Published in:
- Journal of Managed Care Medicine, 2014, v. 17, n. 1, p. 47
- By:
- Publication type:
- Article
Navigating Current and Emerging Approaches in the Treatment and Management of Hemophilia.
- Published in:
- Journal of Managed Care Medicine, 2021, v. 24, n. 4, p. 20
- By:
- Publication type:
- Article